20 October 2017
News and Views
Links and Services
This week's New England Journal of Medicine investigates obeticholic acid administered with ursodiol or as monotherapy for 12 months in patients with primary biliary cholangitis.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors